Edition:
United States

SciGen Ltd (SIE.AX)

SIE.AX on Australia Stock Exchange

0.01AUD
29 Sep 2016
Change (% chg)

-- (--)
Prev Close
$0.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
329,779
52-wk High
$0.02
52-wk Low
$0.00

Summary

Name Age Since Current Position

Marek Dziki

2016 Chairman of the Board

James Kim

2016 Chief Executive Officer, Director

Adam Polonek

38 2012 Chief Financial Officer, Non-Executive Director

Saw Imm Low

63 2009 Senior Vice President, Company Secretary, Executive Director

Yvonne Lim

2010 Group Financial Controller

Won Kee Kim

2016 Executive Director

Jean-Claude Balducci

Country Manager, Australia and New Zealand

Liza Domingo

Country Manager, Philippines

Li Minyi

2011 Accounts Executive

Hedy Ong

2011 Finance and Logistics Manager

Marcus Poh

Regional Marketing Manager

Chander Sharma

Business Development Executive

Edward Thomas

2011 Business Development Executive

Sharon Walters

Business Development Executive

Leng Wong Lai

2002 Company Secretary

Marcin Dukaczewski

38 2008 Non-Executive Director

Mateusz Kosecki

40 2009 Non-Executive Director

Kenneth Gross

85 Independent Non-Executive Director

Biographies

Name Description

Marek Dziki

Dr. Marek Dziki is the Chairman of the Board of the Board of the Company. Dr. Marek Dziki, is a medical doctor with a PhD from the University in Lublin, Poland. In 1998 he completed his MBA at the International Business School in Warsaw and in 2005 completed another MBA from Merck University (Kellog Business School, Chicago, Hong Kong University of Science and Technology and Business School in Fountaineblue.

James Kim

Dr. James W. Kim is Chief Executive Officer, Director of the Company. He is the Director of Business Development and Licensing of Bioton S.A, is a graduate from the Trinity International University, Illinois. He completed his postgraduate studies and earned his doctorate in Biochemistry from the University of Wisconsin - Madison. Dr. Kim worked with LG Life Sciences Ltd serving in functions of corporate business development, diagnostics strategy & planning and business strategy for business areas including pharmaceuticals, biologicals and in vitro diagnostics. Between 2009 and 2011 he worked for Bioneer Corporation in Korea as Team Leader for molecular diagnostics technical support and Senior Scientist and Manager for the development of molecular diagnostics based service platforms.

Adam Polonek

Mr. Adam Tomasz Polonek serves as Chief Financial Officer and Non-Executive Director of SciGen Ltd since January 12, 2012. He is a graduate of the Economic Faculty at Academy of Economics in Poland. Mr. Polonek joined Bioton S.A. in 2006 as Deputy Finance Director and since April 2009 as the Finance Director. He was appointed to the position of Chief Financial Officer of SciGen Ltd in January 2013 and holds finance-related positions in other subsidiaries of SciGen and the Bioton Group. Mr. Polonek’s professional experience includes successful career in one of the leading investment bank in CEE Europe, CAIB Financial Advisers, which is part of the leading banking Group Unicredit in Europe. During Mr. Polonek’s career, he was involved in several Corporate Finance transactions and he has vast experience in stock exchange markets.

Saw Imm Low

Ms. Saw Imm (Jenny) Low serves as Senior Vice President, Company Secretary and Executive Director of SciGen Ltd. She has been with the company for over 20 years, is the longest service staff member and has been involved in many areas of the Company’s operations, including the listing of the Company in ASX. Prior to her appointment as the Senior Vice President in October 2006, Ms. Low was the Chief Financial Officer of the Company. She is a Chartered Accountant, held senior accountancy positions in various companies in both Malaysia and Singapore. With over 30 years of accounting experience, she is well versed with accounting practices and tax laws of the Asia-Pacific region. Before joining SciGen in September 1991, Ms. Low was with Abacus Distribution Systems Pte Ltd, a company owned jointly by the major airline companies in Asia.

Yvonne Lim

Won Kee Kim

Dr. Won Kee Kim is an Executive Director of the Company. Dr. Kim, the Director of Business Development and Licensing of Bioton S.A, is a graduate from the Trinity International University, Illinois. He completed his postgraduate studies and earned his doctorate in Biochemistry from the University of Wisconsin - Madison. Dr. Kim worked with LG Life Sciences Ltd serving in functions of corporate business development, diagnostics strategy & planning and business strategy for business areas including pharmaceuticals, biologicals and in vitro diagnostics. Between 2009 - 2011 he worked for Bioneer Corporation in Korea as Team Leader for molecular diagnostics technical support and Senior Scientist and Manager for the development of molecular diagnostics-based service platforms.

Jean-Claude Balducci

Liza Domingo

Li Minyi

Hedy Ong

Marcus Poh

Chander Sharma

Edward Thomas

Sharon Walters

Leng Wong Lai

Marcin Dukaczewski

Mr. Marcin Dukaczewski serves as Non-Executive Director of SciGen Ltd since December 26, 2008. Mr. Marcin Dukaczewski was trained in International Political and Economical Relations at the Warsaw University (Uniwersytet Warszawski). Mr. Dukaczewski holds the position of Vice President of the Management Board of Prokom Investments – a Polish private-equity fund being the strategic investor in Bioton S.A. He is also a member of the Supervisory Board of public listed companies listed on the Warsaw Stock Exchange: Bioton (biotechnology), Petrolinvest (oil & gas exploration) and Polnord (real estate development). Mr. Dukaczewski is also a member of the Supervisory Board of Biolek (veterinary products), Silurian (shale gas exploration) and a member of the Board of Directors of Biolek, Inc in Canada.

Mateusz Kosecki

Mr. Mateusz Patryk Kosecki serves as Non-Executive Director of SciGen Ltd since December 1, 2009. Mr. Mateusz Kosecki is a graduate of the Executive MBA Program of European University, Montreux, Switzerland. He is the Foreign Markets Director of Bioton S.A. and is responsible for the operations of the company on overseas market. He is also the Vice President of Biolek Sp z.o.o., a member of Bioton Group. Mr. Kosecki has experience in international business. From 1995 to 1996 he worked as the Marketing Manager in Lenex Company in Sofia, Bulgaria. From 1997 to 2001 he was Head of Foreign Corporate Governance and Operations of Ciech S.A. He has been connected with pharmaceutical industry for 10 years. From 2002 to 2006, as the Country Manager for Russia of the Polish pharmaceutical company Ciech Polfa, and from 2006 to 2009 as Regional Director for Eastern Europe in Bioton S.A.

Kenneth Gross

Mr. Kenneth Gross is Independent Non-Executive Director of SciGen Ltd. Mr. Kenneth Gross co-founded Goldmark Plastic Compounds in 1957. The Company has since become a distributor of plastic raw materials within the United States. In addition, Mr. Gross holds a number of directorships in various companies involved in chemical, metals, engineering resins and lubricating oils.